Patent details
EP4333831 Title: TOPICAL FORMULATION OF AN ANTICHOLINERGIC COMPOUND FOR TREATING SEVERE HYPERHIDROSIS AND EXCESSIVE SWEATING
Basic Information
- Publication number:
- EP4333831
- PCT Application Number:
- EP2023059763
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP237158928
- PCT Publication Number:
- WO2023198876
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TOPICAL FORMULATION OF AN ANTICHOLINERGIC COMPOUND FOR TREATING SEVERE HYPERHIDROSIS AND EXCESSIVE SWEATING
- French Title of Invention:
- FORMULATION TOPIQUE D'UN COMPOSÉ ANTICHOLINERGIQUE POUR LE TRAITEMENT DE L'HYPERHIDROSE SÉVÈRE ET DE LA TRANSPIRATION EXCESSIVE
- German Title of Invention:
- TOPISCHE FORMULIERUNG EINER ANTICHOLINERGEN VERBINDUNG ZUR BEHANDLUNG VON SCHWERER HYPERHIDROSE UND ÜBERMÄSSIGEM SCHWITZEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 04/09/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 23/09/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 14/08/2024
- Unitary Effect Registration Date:
- 23/09/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 14/04/2023
- Grant date:
- 14/08/2024
- EP Publication Date:
- 13/03/2024
- PCT Publication Date:
- 19/10/2023
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/08/2024
- EP B1 Publication Date:
- 14/08/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 14/04/2043
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 07/08/2024
- Name:
- Dr. August Wolff GmbH & Co. KG Arzneimittel
- Address:
- Sudbrackstrasse 56, 33611 Bielefeld, Germany (DE)
Inventor
1
- Name:
- DR. SCHULZE ZUR WIESCHE, Erik
- Address:
- Germany (DE)
2
- Name:
- DR. NEUHAUS, Bernhard
- Address:
- Germany (DE)
3
- Name:
- DR. MASUR, Clarissa
- Address:
- Germany (DE)
Priority
1
- Priority Number:
- 22168549
- Priority Date:
- 14/04/2022
- Priority Country:
- European Patent Office (EPO) (EP)
2
- Priority Number:
- 22178325
- Priority Date:
- 10/06/2022
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 31/216; A61K 31/40; A61K 31/439; A61P 17/00; A61K 9/00; A61K 9/06; A61K 47/10;
Publication
European Patent Bulletin
1
- Issue number:
- 202433
- Publication date:
- 14/08/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202441
- Publication date:
- 09/10/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202443
- Publication date:
- 23/10/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|